This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Emory University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Guo Chen: Innovator in Cancer Therapy
Introduction
Guo Chen is a prominent inventor based in Atlanta, GA, specializing in innovative approaches to cancer therapy. His work focuses on enhancing the effectiveness of cancer treatments through the development of novel inhibitors.
Latest Patents
Guo Chen holds a patent titled "Targeting Mcl-1 to enhance DNA replication stress sensitivity for cancer therapy." This patent relates to inhibitors of Mcl-1 that stimulate homologous recombination (HR) DNA repair, providing new methods for treating cancer. The disclosure outlines methods of administering an inhibitor of Mcl-1 in combination with other anti-cancer agents, such as hydroxyurea and olaparib, to induce DNA replication stress and improve treatment outcomes.
Career Highlights
Guo Chen is affiliated with Emory University, where he contributes to cutting-edge research in cancer therapy. His innovative work has the potential to significantly impact the field of oncology, offering new hope for patients undergoing treatment.
Collaborations
Guo Chen collaborates with esteemed colleagues, including Xingming Deng and Abu Syed Md Anisuzzaman, to advance research in cancer therapies and improve patient outcomes.
Conclusion
Guo Chen's contributions to cancer therapy through his innovative patent demonstrate his commitment to improving treatment options for patients. His work at Emory University and collaborations with fellow researchers highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile